Perrigo Company reports Q1 2026 results today against a backdrop where short sellers have been quietly covering — but the stock's fastest rally in months arrives at a level that still sits well below where analysts valued it a year ago.
The short-side retreat is the clearest setup signal heading into the print. Short interest has fallen roughly 13% over the past month to 9.8% of the free float — still a meaningful level, but the directional move matters. The sharpest step-down came around April 23, when shares short dropped from roughly 15.7 million to 13.8 million in a single session, a reduction that tracked the stock's own sharp bounce. Borrow conditions offer little friction for new short positions: cost to borrow is a modest 0.44%, down about 15% over the past month, and the lending pool remains comfortable with shares available. That combination — falling short interest, cheap borrow, ample availability — reads less like a squeeze and more like bears choosing to exit rather than being forced out.
Options positioning tells a mildly more cautious story, though nothing dramatic. The put/call ratio has drifted to 0.27, slightly above its 20-day average of 0.23, putting it about one standard deviation above recent norms. Call-dominated flow still dominates — the PCR's 52-week high is 0.97 — so the move is a nudge toward hedging rather than a defensive repositioning. The stock itself has been on a strong run: up 5.3% on Wednesday, 8.6% on the week, and 13% over the past month, closing at $12.26. The RSI sits at a neutral 53.7, suggesting the recent move hasn't pushed the stock into technically overbought territory.
The analyst backdrop frames the bull-bear debate starkly. The most recent consensus target, struck in late February, was $17 — roughly 39% above the current price — but the trend of analyst revisions has been relentlessly downward. JPMorgan downgraded the stock to Neutral from Overweight last November, cutting its target from $32 to $20. Canaccord kept its Buy rating through that same period but slashed its target from $40 to $17 by February. The direction of travel — multiple firms trimming targets across several quarters — reflects a bull case tested by execution. The last earnings event, the Q4 2025 report in late February, sent the stock down 13% on the day and nearly 24% over the following five days, a reaction that underscores how sensitive the shares are to any miss against expectations. With the stock now trading at a P/E near 5x and an EV/EBITDA of roughly 7.7x, valuation is clearly not the constraint — the constraint is whether management can demonstrate the kind of earnings stability needed to rebuild credibility with a market that has cut targets in half over the past year.
Today's print is therefore less about whether Perrigo can generate revenue — consensus pencils in around $1 billion for the quarter — and more about whether the guidance trajectory and margin delivery are strong enough to justify the recent rally and arrest the multi-quarter pattern of downward analyst revision.
See the live data behind this article on ORTEX.
Open PRGO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
